Exact Sciences (EXAS) Short Interest Ratio & Short Volume $46.71 +0.60 (+1.30%) Closing price 04:00 PM EasternExtended Trading$46.82 +0.12 (+0.25%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Exact Sciences Short Interest DataExact Sciences (EXAS) has a short interest of 6.88 million shares, representing 3.68% of the float (the number of shares available for trading by the public). This marks a -7.90% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 2.78 million shares to cover all short positions.Current Short Interest6,880,000 sharesPrevious Short Interest7,470,000 sharesChange Vs. Previous Month-7.90%Dollar Volume Sold Short$323.02 millionShort Interest Ratio2.2 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares189,320,000 sharesShort Percent of Float3.68%Today's Trading Volume2,146,231 sharesAverage Trading Volume2,780,808 sharesToday's Volume Vs. Average77% Short Selling Exact Sciences? Sign up to receive the latest short interest report for Exact Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEXAS Short Interest Over TimeEXAS Days to Cover Over TimeEXAS Percentage of Float Shorted Over Time Exact Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20256,880,000 shares $323.02 million -7.9%3.7%2.2 $46.95 7/15/20257,470,000 shares $395.84 million +6.4%N/A2.6 $52.99 6/30/20257,020,000 shares $373.04 million -11.5%3.8%2.3 $53.14 6/15/20257,930,000 shares $424.41 million -25.7%4.3%2.8 $53.52 5/31/202510,670,000 shares $599.01 million -4.2%5.8%3.8 $56.14 5/15/202511,140,000 shares $625.73 million +10.1%6.1%4.3 $56.17 4/30/202510,120,000 shares $461.88 million -5.7%N/A4 $45.64 4/15/202510,730,000 shares $468.58 million -3.9%5.9%4.6 $43.67 3/31/202511,170,000 shares $483.55 million +5.4%6.1%4.6 $43.29 3/15/202510,600,000 shares $477 million -0.6%5.8%4.9 $45.00 Get the Latest News and Ratings for EXAS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exact Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/28/202510,660,000 shares $505.39 million +4.4%5.8%4.9 $47.41 2/15/202510,210,000 shares $503.46 million +2.8%5.6%4.7 $49.31 1/31/20259,930,000 shares $556.58 million -3.5%N/A3.9 $56.05 1/15/202510,290,000 shares $550.72 million -3.7%N/A4 $53.52 12/31/202410,690,000 shares $600.67 million -4.6%N/A4.6 $56.19 12/15/202411,200,000 shares $686 million -5.3%N/A4.7 $61.25 11/30/202411,830,000 shares $734.41 million -14.5%N/A4.4 $62.08 11/15/202413,840,000 shares $682.73 million -1.6%N/A5.1 $49.33 10/31/202414,060,000 shares $969.16 million -9.5%N/A5.9 $68.93 10/15/202415,540,000 shares $1.09 billion +10.8%N/A6.4 $69.95 9/30/202414,030,000 shares $955.72 million -14.6%N/A5.4 $68.12 9/15/202416,420,000 shares $1.08 billion +13.2%N/A5.9 $65.54 8/31/202414,510,000 shares $895.12 million +5.0%N/A5.3 $61.69 8/15/202413,820,000 shares $808.06 million +1.7%N/A4.8 $58.47 7/31/202413,590,000 shares $620.79 million -2.8%N/A4.1 $45.68 7/15/202413,980,000 shares $657.76 million -1.6%N/A4.7 $47.05 6/30/202414,210,000 shares $600.37 million +50.4%N/A4.7 $42.25 6/15/20249,450,000 shares $395.77 million +7.6%N/A3 $41.88 5/31/20248,780,000 shares $399.05 million +3.3%N/A3 $45.45 5/15/20248,500,000 shares $453.39 million -4.3%N/A2.9 $53.34 4/30/20248,880,000 shares $527.03 million -10.2%N/A3.6 $59.35 4/15/20249,890,000 shares $646.31 million +56.0%N/A4.1 $65.35 3/31/20246,340,000 shares $437.84 million -2.8%N/A2.8 $69.06 3/15/20246,520,000 shares $376.27 million -7.4%N/A3.4 $57.71 2/29/20247,040,000 shares $405.01 million -3.2%N/A3.6 $57.53 2/15/20247,270,000 shares $444.12 million -0.3%N/A4 $61.09 1/31/20247,290,000 shares $476.77 million -4.1%N/A4.3 $65.40 1/15/20247,600,000 shares $510.11 million +1.3%N/A4.6 $67.12 12/31/20237,500,000 shares $554.85 million +5.8%N/A4.5 $73.98 12/15/20237,090,000 shares $467.23 million -3.5%N/A4.4 $65.90The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency. 11/30/20237,350,000 shares $470.40 million +0.8%N/A5.1 $64.00 11/15/20237,290,000 shares $460.14 million -3.7%N/A5.1 $63.12 10/31/20237,570,000 shares $466.24 million -7.3%N/A5.4 $61.59 10/15/20238,170,000 shares $533.26 million +7.8%N/A5.8 $65.27 9/30/20237,580,000 shares $517.11 million -11.7%N/A5.3 $68.22 9/15/20238,580,000 shares $657.91 million +0.4%N/A6.3 $76.68 8/31/20238,550,000 shares $715.38 million +1.9%N/A5.5 $83.67 8/15/20238,390,000 shares $721.71 million -2.9%N/A5.2 $86.02 7/31/20238,640,000 shares $842.75 million -4.4%N/A4.7 $97.54 7/15/20239,040,000 shares $875.70 million +1.8%N/A5.1 $96.87 6/30/20238,880,000 shares $833.83 million -13.0%N/A5 $93.90 6/15/202310,210,000 shares $953.51 million +8.9%N/A5.4 $93.39 5/31/20239,380,000 shares $765.22 million -4.4%N/A5 $81.58 5/15/20239,810,000 shares $793.92 million -11.7%N/A4.7 $80.93 4/30/202311,110,000 shares $711.82 million -3.2%N/A5.8 $64.07 4/15/202311,480,000 shares $766.75 million -2.7%N/A5.7 $66.79 3/31/202311,800,000 shares $800.16 million -4.7%N/A4.8 $67.81 3/15/202312,380,000 shares $796.78 million -5.3%N/A4.9 $64.36 2/28/202313,070,000 shares $814.65 million +18.2%N/A4.9 $62.33 2/15/202311,060,000 shares $731.51 million -7.0%N/A4.4 $66.14 1/31/202311,890,000 shares $802.81 million -7.5%N/A4.6 $67.52 1/15/202312,850,000 shares $886.14 million +11.8%N/A4.8 $68.96 12/30/202211,490,000 shares $568.87 million +15.1%N/A4.6 $49.51 12/15/20229,980,000 shares $445.21 million -1.4%N/A4.2 $44.61 11/30/202210,120,000 shares $454.89 million +2.0%N/A4.7 $44.95 11/15/20229,920,000 shares $439.26 million -2.6%N/A4.4 $44.28 10/31/202210,180,000 shares $354.06 million -4.1%N/A4.3 $34.78 10/15/202210,620,000 shares $322.32 million -9.2%N/A4.7 $30.35 9/30/202211,690,000 shares $379.81 million +4.2%N/A5.4 $32.49 9/15/202211,220,000 shares $458.79 million +14.0%N/A5.2 $40.89 8/31/20229,840,000 shares $349.81 million +4.5%N/A4.5 $35.55 8/15/20229,420,000 shares $416.74 million -2.9%N/A4.4 $44.24 7/31/20229,700,000 shares $437.47 million -9.7%N/A4.5 $45.10 7/15/202210,740,000 shares $503.71 million -3.1%N/A4.8 $46.90 6/30/202211,080,000 shares $436.44 million +1.3%N/A5 $39.39 6/15/202210,940,000 shares $423.27 million -5.2%N/A5 $38.69 5/31/202211,540,000 shares $574.81 million -14.6%N/A5.7 $49.81 5/15/202213,520,000 shares $706.96 million -0.5%N/A6.6 $52.29 4/30/202213,590,000 shares $748.13 million -4.2%N/A7.1 $55.05 4/15/202214,180,000 shares $987.07 million +3.1%N/A7.5 $69.61 3/31/202213,760,000 shares $962.10 million +1.8%N/A6.8 $69.92 3/15/202213,520,000 shares $778.21 million +5.0%N/A6.6 $57.56 2/28/202212,880,000 shares $1.01 billion +8.1%N/A6.2 $78.06 2/15/202211,920,000 shares $968.86 million -1.9%N/A5.6 $81.28 1/31/202212,150,000 shares $927.77 million +5.7%N/A6 $76.36 1/15/202211,500,000 shares $901.95 million +1.1%N/A5.7 $78.43 12/31/202111,370,000 shares $884.93 million -5.8%N/A6.6 $77.83 12/15/202112,070,000 shares $961.50 million -3.4%N/A7.5 $79.66 11/30/202112,500,000 shares $1.07 billion +4.2%N/A8.1 $85.37 11/15/202112,000,000 shares $1.08 billion +0.3%N/A8.3 $89.97The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency. 10/29/202111,960,000 shares $1.14 billion -6.2%N/A8.3 $95.22 10/15/202112,750,000 shares $1.26 billion +19.4%N/A9.2 $98.96 9/30/202110,680,000 shares $1.02 billion -1.6%N/A7.7 $95.45 9/15/202110,850,000 shares $1.14 billion +9.5%N/A8.3 $104.65 8/31/20219,910,000 shares $1.03 billion +6.0%N/A7.6 $104.38 8/13/20219,350,000 shares $868.99 million +3.7%N/A7 $92.94 7/30/20219,020,000 shares $972.72 million +1.5%N/A6.3 $107.84 7/15/20218,890,000 shares $989.99 million -4.7%N/A6.4 $111.36 6/30/20219,330,000 shares $1.16 billion -0.2%N/A6.6 $124.31 6/15/20219,350,000 shares $1.15 billion -0.6%N/A6.4 $122.57 5/28/20219,410,000 shares $1.04 billion +1.3%N/A6.3 $110.53 5/14/20219,290,000 shares $870.10 million -2.1%N/A5.8 $93.66 4/30/20219,490,000 shares $1.26 billion -2.5%N/A5.9 $133.02 4/15/20219,730,000 shares $1.24 billion +1.7%N/A6 $127.14 3/31/20219,570,000 shares $1.18 billion +8.1%N/A5.3 $123.65 3/15/20218,850,000 shares $1.14 billion +4.1%N/A4.9 $128.46 2/26/20218,500,000 shares $1.12 billion +1.0%N/A4.6 $131.30 2/12/20218,420,000 shares $1.24 billion -1.1%N/A4.7 $146.68 1/29/20218,510,000 shares $1.19 billion -9.0%N/A5.2 $139.55 1/15/20219,350,000 shares $1.38 billion -4.2%N/A4.6 $147.29 12/31/20209,760,000 shares $1.32 billion -7.7%N/A5.2 $135.40 12/15/202010,570,000 shares $1.37 billion -2.0%N/A4.9 $129.80 11/30/202010,780,000 shares $1.27 billion -8.5%N/A5 $118.19 11/15/202011,780,000 shares $1.45 billion +1.7%N/A5.5 $122.71 10/30/202011,580,000 shares $1.40 billion -9.7%N/A5.5 $120.51 10/15/202012,830,000 shares $1.33 billion -6.1%N/A7.4 $103.50 9/30/202013,660,000 shares $1.39 billion +8.2%N/A7.8 $101.95 9/15/202012,630,000 shares $966.07 million -4.1%N/A7.8 $76.49 8/31/202013,170,000 shares $991.57 million No ChangeN/A9.3 $75.29 EXAS Short Interest - Frequently Asked Questions What is Exact Sciences' current short interest? Short interest is the volume of Exact Sciences shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 6,880,000 shares of EXAS short. 3.68% of Exact Sciences' shares are currently sold short. Learn More on Exact Sciences' current short interest. What is a good short interest ratio for Exact Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EXAS shares currently have a short interest ratio of 2.0. Learn More on Exact Sciences's short interest ratio. Which institutional investors are shorting Exact Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Exact Sciences: LMR Partners LLP, Group One Trading LLC, Bank of America Corp DE, Ameriprise Financial Inc., Jane Street Group LLC, Caption Management LLC, Squarepoint Ops LLC, Walleye Capital LLC, Walleye Trading LLC, DLD Asset Management LP, Jefferies Financial Group Inc., JPMorgan Chase & Co., Credit Industriel ET Commercial, Simplex Trading LLC, Wolverine Asset Management LLC, Twin Tree Management LP, Credit Industriel ET Commercial, and Quaker Wealth Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Exact Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.68% of Exact Sciences' floating shares are currently sold short. Is Exact Sciences' short interest increasing or decreasing? Exact Sciences saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 6,880,000 shares, a drop of 7.9% from the previous total of 7,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Exact Sciences' short interest compare to its competitors? 3.68% of Exact Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Exact Sciences: Biogen Inc. (2.71%), Incyte Corporation (3.85%), United Therapeutics Corporation (3.56%), Neurocrine Biosciences, Inc. (3.02%), BioMarin Pharmaceutical Inc. (2.71%), Exelixis, Inc. (6.67%), Madrigal Pharmaceuticals, Inc. (22.84%), Halozyme Therapeutics, Inc. (8.58%), Repligen Corporation (6.84%), Ionis Pharmaceuticals, Inc. (7.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Exact Sciences stock? Short selling EXAS is an investing strategy that aims to generate trading profit from Exact Sciences as its price is falling. EXAS shares are trading up $0.45 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Exact Sciences? A short squeeze for Exact Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EXAS, which in turn drives the price of the stock up even further. How often is Exact Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EXAS, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies BIIB Short Interest Data INCY Short Interest Data UTHR Short Interest Data NBIX Short Interest Data BMRN Short Interest Data EXEL Short Interest Data MDGL Short Interest Data HALO Short Interest Data RGEN Short Interest Data IONS Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EXAS) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access